Search for: "Pharmaceutical Associates, Inc."
Results 341 - 360
of 1,890
Sort by Relevance
|
Sort by Date
6 Mar 2018, 2:10 pm
We are doing this review because it was during April 2013 that Novartis Pharmaceuticals Canada Inc. took these actions: Sent a so-called "Dear Doctor" letter in Canada (but not the US) warning about some serious side effects associated with Tasigna; and, Issued a Tasigna drug label change in Canada (but not the US) with new information concerning those Tasigna side effects. [read post]
6 Mar 2018, 2:10 pm
In closing this article, I will point out that as of today, nearly five years after the actions taken by Novartis Pharmaceuticals Canada Inc., in the US there still has not been any "Dear Doctor" letter nor any Tasigna drug label change made by Novartis Pharmaceuticals Corporation similar to what was done in Canada during April 2013. [read post]
2 Mar 2018, 11:26 am
Jansen Pharmaceuticals, part of Johnson & Johnson, devloped the drug and manufactures it. [read post]
27 Feb 2018, 9:12 am
Relevant parts of this April 9, 2013 letter from Novartis Pharmaceuticals Canada Inc. are set forth below: Dear Healthcare Professional: Subject: Updated information regarding the possible risk of developing atherosclerosis-related diseases with the use of TASIGNA* (nilotinib) Novartis Pharmaceuticals Canada Inc. [read post]
22 Feb 2018, 8:00 am
On June 15, 2015, Mroczko filed suit against Pepper, Perez, Blue Cross and Interface America Inc. for injuries she sustained 34 months prior. [read post]
14 Feb 2018, 9:00 pm
“There are many food safety hazards associated with cannabis production and distribution that could put the public at risk, but are not yet adequately controlled,” Steven Burton of Icicle Technologies Inc. said earlier this month. [read post]
14 Feb 2018, 2:57 pm
ANZ Securities, Inc. [read post]
12 Feb 2018, 11:59 am
Settlements with American Medical Systems, Inc. [read post]
7 Feb 2018, 7:27 am
Reddy’s Laboratories, Inc. [read post]
18 Jan 2018, 9:34 am
WARNING LETTERMark BaumImprimis Pharmaceuticals Inc.12264 El Camino Real, Suite 350San Diego, CA 92130Dear Mr. [read post]
18 Jan 2018, 2:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
15 Jan 2018, 11:40 am
Call Associates and Bruce L. [read post]
14 Jan 2018, 6:34 am
Medtronic, Inc. (2008) 552 U.S. 312, 329; cf. [read post]
11 Jan 2018, 12:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc. is the drug company responsible for OFEV in the US. [read post]
2 Jan 2018, 5:08 pm
As of December 29, 2017, the Senate has confirmed including 19 Trump administration judicial nominees, including one Associate Justice of the Supreme Court, 12 judges for the United States Courts of Appeals, and six judges for the United States District Courts. [read post]
2 Jan 2018, 4:12 pm
Regeneron Pharmaceuticals, Inc. v. [read post]
28 Dec 2017, 2:18 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
8 Dec 2017, 12:45 pm
" page of the Limbrel.com website (accessed 12/8/17) which is presented by Primus Pharmaceuticals, Inc.: Limbrel contains flavocoxid, a proprietary blend of natural ingredients from phytochemical food source materials. [read post]
5 Dec 2017, 7:40 am
Here are the amici curiae in the matter of Mylan Pharmaceuticals Inc. et al v. [read post]
17 Nov 2017, 7:44 am
District Court for the Northern District of Illinois jury ordered pharmaceutical manufacturer AbbVie Inc. to pay $150 million in damages to Oregon resident Jesse Mitchell after he filed a suit claiming the company’s AndroGel product led to a heart attack in 2012. [read post]
